Lori Waldron of Sills Cummis & Gross in Newark had an eventful 2018. In addition to becoming co-chair of her practice group, she handled numerous significant deals, including her representation of Progenics Pharmaceuticals Inc. in an exclusive license agreement with Curium Netherlands Holding B.V. in connection with a Progenics oncology imaging agent. She “has tripled her book of business over the last two years,” a colleague said. “Lori spent part of her career in-house and understands the pressures in-house lawyers and businesspeople face. This experience gives Lori insight that a lot of lawyers are missing—she is a businessperson as much as she is a lawyer, allowing her to get deals done for her clients.”

What were some of your most satisfying successes of 2018, and why?